ARTICLE | Clinical News
NGAL Test regulatory update
July 11, 2016 7:00 AM UTC
BioPorto said it will continue to seek FDA approval of its NGAL Test to detect acute kidney injury following discussions with the agency and anticipates “approval within 18-24 months.” In late May, FD...